Genetic polymorphisms and their correlation with dyslipidemia in Chinese patients diagnosed with diabetes mellitus
Qian-Wen Ma, Hui-Hui Wu, Yi-Meng Liu, Pu Zhao, Xiao-Yu Li, Department of Endocrinology and Metabolism, Jing'an District Center Hospital of Shanghai, Fudan University, Shanghai, 200040, China
Jie Wen, Department of Endocrinology and Metabolism, Huashan Hospital of Fudan University, Shanghai, 200040, China
Co-first authors: Qian-Wen Ma and Hui-Hui Wu.
Author contributions: Ma QW and Wu HH proposed the concept of this study and jointly wrote the first draft; Liu YM validated this study; Li XY contributed to data collection; Wu HH contributed to formal analysis; Ma QW and Wen J participated in the survey; Ma QW and Wen J contributed to the methods; Zhao P contributed to the visualization of this study; all authors collectively guided the research, reviewed, and edited the manuscript; Ma QW and Wu HH, as the first authors, made equal contributions to this work. After discussion among all authors, it has been decided to designate Ma QW and Wu HH as the first authors for three main reasons. Firstly, this study was conducted as a collaborative effort, and it is reasonable to designate a joint first author. The author accurately reflects the distribution of responsibilities and burdens related to the time and effort required to complete the research and final manuscript. Designating two co first authors will ensure effective communication and management of post submission matters, thereby improving the quality and reliability of the paper. Secondly, the co-first authors of the research team possess diverse professional knowledge and skills from different fields, and their appointments best reflect this diversity. It also promotes the most comprehensive and in-depth exploration of research topics, ultimately enriching readers' understanding by providing various expert perspectives. Thirdly, Ma QW and Wu HH made substantial and equal contributions throughout the entire research process. Choosing these researchers as co first authors, acknowledging and respecting their equal contributions, demonstrates the spirit of collaboration and teamwork in this study. We believe that designating Ma QW and Wu HH as co first authors is suitable for our manuscript, as it accurately reflects the collaborative spirit, equal contribution, and diversity of our team.
Supported by National Nature Science foundation of China, No. 81900755; and the Health Commission of Shanghai Municipality, No. 20194Yo384.
Institutional review board statement: This study has been reviewed and approved by the Ethics Committee of Jing'an District Central Hospital affiliated with Fudan University in Shanghai.
Informed consent statement: This study has obtained the consent of patients and guardians, and an informed consent form has been signed.
Conflict-of-interest statement: Dr. Wen has nothing to disclose.
Data sharing statement: No data available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Jie Wen, MD, Chief Physician, Department of Endocrinology and Metabolism, Huashan Hospital of Fudan University, No. 12 Urumqi Middle Road, Shanghai 200433, China. wenjie065@126.com
Received: April 24, 2024
Revised: May 14, 2024
Accepted: May 15, 2024
Published online: July 16, 2024
Processing time: 66 Days and 16.6 Hours
